Home / D360 Scientific Informatics Platform

D360™

Data-driven drug discovery delivered

Shorten the design-make-test-analyze cycle with D360

Is your research informatics software designed to support an efficient drug discovery process? The D360™ Scientific Informatics Platform is the industry-leading solution for small molecule and sequence-based modalities research, whose versatility and low total cost of ownership have made it the analysis and visualization system of choice for discovery teams globally. Designed to empower scientists, D360 offers seamless access to your enterprise data — from compound informatics and bioactivity parameters to operational data like inventory — along with integrated tools for visualization, analysis, and collaboration.

The result is an accelerated Design-Make-Test-Analyze cycle, informed by the best possible scientific decisions and operational efficiency. Trusted by top pharmaceutical companies and innovative biotechs, D360 is revolutionizing data-driven scientific research.

Accelerates the Design-Make-Test-Analyze cycle for drug discovery

More than 6,000 research scientists worldwide rely on D360

Trusted by the top 10 pharmaceutical companies globally

Empowering drug discovery with self-service data access and advanced analytics

D360 Scientific Informatics Platform revolutionizes drug discovery by offering unparalleled self-service data access and analysis capabilities. It integrates seamlessly with data sources, enabling scientists to create custom dashboards, automate data workflows, and visualize complex datasets with ease. Whether working with small molecules, antibodies, oligos, or any other modality, D360 ensures consistent data handling and analysis, empowering teams to make informed decisions faster.

Self-service data search with drag-and-drop interfaces and shareable queries.
Advanced visualization tools, including scatter plots, histograms, and clustering.
Supports research into small molecules, peptides, oligos, antibodies, ADCs and other modalities, combining general data analytics with structure and sequence-based analysis.

How scientists and research IT benefit

Self-service data access

D360 provides self-service data access to scientists through intuitive drag and drop interfaces, eliminating reliance on research IT teams. New assays are automatically discovered. Queries can be shared as one-click dashboard widgets to data views shared with other research team members.

Advanced data visualization

Visualize data correlations, distributions and trends. Understand structure and sequence activity relationships. All data visualizations can be automated so scientists can spend more time on science rather than software.

Analytics for small molecules, peptides, antibodies, and more

Specialized analytics for structure and sequence activity relationships from Clustering, R-Group and transformation analysis to sequence alignment.

Data views for all your data-related decision making

Present data in spreadsheet or form views depending on your task or preference. Spreadsheets for prioritization, forms for rich, hierarchical data views.

D360 and D360 Partner Setup

External research partners can use D360 Partner to access project-relevant data views provided by the sponsor company through their existing D360 installation.

Secure data access and collaboration with research partners

Allow seamless, secure sharing of your data and analyses with external partners through D360 Partner. Your partners share your data views and analysis tools but have no access to unauthorized data. Add partners in seconds to share information, annotations, and ideas.

Why Certara

Certara delivers leading-edge solutions that empower scientists to make data-driven decisions, accelerating drug discovery timelines and improving outcomes.

  • Early drug discovery is a core area of expertise at Certara, supported by a team of highly experienced and renowned experts in the field.
  • The dynamic community of users from drug discovery empowers us to continuously refine our solutions to meet the ever-evolving demands of innovative research.

"D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.”

Dr. Keith Hornberger
Director of Chemistry, Arvinas

Related resources

View all
1 / 6
Video

Applying AI-Driven Biosimulation to Drug Discovery

Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs, can be brought upstream into drug discovery to reduce Phase I failure rates, accelerate candidate selection, and enable digital-first DMTA workflows with agentic AI.
Watch now
2 / 6
Announcement

Certara Enables Discovery Scientists to Accelerate Therapeutic Peptide Discovery with New D360 version

Discover how D360 26.0 enhances peptide design, sequence analysis, and workflows to help scientists accelerate drug discovery and improve candidate selection.
Read more
3 / 6
On-Demand Webinar

Safety First: Uncovering the Clinical Risks Inside Your Compound Screening Data

Learn how to interpret screening assay data to predict clinical off-target risk with ToxStudio® and D360™ —and stratify safety early in the DMTA cycle.
Watch now
4 / 6
On-Demand Webinar
6 / 6
Blog

How Drug Discovery Tools Aid Pharma Decision-Making

Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based on robust data analytics
Read more

With D360, your data is secure

Certara holds ISO 27001 certification for Certara’s Information Security Management System (ISMS). We have implemented robust security controls, undergone rigorous risk assessments, and continuously strive for improvement. D360 ensures full compliance with global data protection standards, offering peace of mind for sensitive analysis.

Learn more in our Trust Center

Schedule a demo

Schedule a demo today to see how D360 empowers your team with advanced data visualization, analysis, and collaboration tools.

Query research data efficiently across different data sources
Spend more time on science and less time on data wrangling
Make effective go/no-go decisions faster


FAQs

What types of data can D360 handle?

D360 supports chemical structure, sequence, and HELM representations for therapeutic modality structure/sequence including non-natural monomers. D360 supports all types of assay data for efficacy, selectivity, ADMET and PK data including rendering of Dose-response curves.

How does D360 facilitate collaboration between internal teams and external research partners?

D360 supports joint internal/external research teams through the D360 Partner add-on which provides query and annotation sharing with external research partners while ensuring data security. Learn more about D360 Partner.

Is D360 suitable for smaller pharmaceutical organizations with limited IT resources?

Because of its extremely low maintenance overhead and scalability, D360 is suitable for organizations ranging from top 10 multi-national, multi-site large pharmaceutical companies down to small biotechnology research organizations. D360 Express is tailored for smaller organizations offering quick deployment, pre-configured connectors, and a standard adoption plan. Learn more about D360 Express.

What integrations are available with D360 for enhanced research capabilities?

D360 integrates with leading tools such as Design Hub, Scilligence, CDD Vault, and Optibrium, offering comprehensive discovery informatics solutions. Learn more about our partners.

Can D360 be used programmatically?

Yes, D360 provides a rich array of REST services to allow programmatic query execution and data access for computational processes. This capability has grown significantly to feed D360 cleansed and aggregated data into AI and ML learning.